Z. W. Wong

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

M. Ellis, Y. Tao, L. Harris, 2007, Breast Cancer Research and Treatment.

T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes

C. Ong, O. Rotzschke, Bernett Lee, 2021, Cancers.